Related Links Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Screening Study of Biomarkers Associated With the Early Detection of Lung Cancer in Participants at High- or Low-Risk For Smoking-Related Cancer

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs No phase specified Biomarker/Laboratory analysis, Screening Active Over 50 NCI NYU-H-8896-06-B NCT00301119

Trial Description

Purpose:

Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer.

This clinical trial is studying biomarkers in screening participants for lung cancer.

Eligibility:

Eligibility criteria include the following:

• At least 50 years old
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Participants will complete a questionnaire and undergo a breathing test, a chest CT scan, and have sputum and blood samples collected. Some participants may undergo bronchoscopy and biopsy, or surgery. Tissue samples will be collected during surgery or biopsy.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NYU Cancer Institute at New York University Medical Center

William Rom, MD, MPH, Principal investigator		Ph: 212-263-6479 Email: william.rom@med.nyu.edu

U.S.A.
New York
	New York
	NYU Cancer Institute at New York University Medical Center
		William Rom, MD, MPH	Ph:  212-263-6479
			Email: william.rom@med.nyu.edu

Registry Information
Official Title		NYU Lung Cancer Biomarker Center
Trial Start Date		2000-05-08
Trial Completion Date		2010-02-28 (estimated)
Registered in ClinicalTrials.gov		NCT00301119
Date Submitted to PDQ		2005-10-04
Information Last Verified		2008-12-07
NCI Grant/Contract Number		U01-CA86137, P30-CA16087